Skip to main content
Caplight Logo









ABANZA

ABANZA

Private
NavarraHealthcare & Life Scienceshttps://www.abanzamed.com/

Last Round

Early Funding

Sep 4, 2024

Total Funding Raised

$5.31M

Company Overview

ABANZA is a medical technology company that develops and manufactures innovative devices for orthopedics and arthroscopic soft tissue repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sports & Fitness

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

soft tissue repairorthopedic implantsACL reconstructionACL repairsports medicinearthroscopysoft tissue fixationMedTechmedical devicessurgical instrumentsgraft fixationligament repairtendon repairFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ABANZA Comparables

Compare ABANZA with similar companies based on industry and business-model similarity.

ABANZA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inovedis, Inc.
84%
Johnson & Johnson
76%
Miach Orthopaedics
76%

ABANZA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 4, 2024
VC RoundMar 9, 2022
SeedFeb 24, 2020

Key People

Founding team and executive leadership

Juan Abascal

CEO And Co-founder

Founding Team

Carolina Crespo Gómara

Chief Operating Officer

Executive Team

Hugo Domínguez

Chief Business Officer & Board Member At ABANZA

Executive Team

ABANZA Investors

Notable investors and investment history

ABANZA investors
InvestorRounds
OrzaSeed
Clave CapitalSeed, VC Round
SodenaDebt, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors grew 2699% MoM, from 195 to 5.5K.

  • Feb 24, 2026

    Grew 21% QoQ, from 28 to 34 employees.

ABANZA Filings

Explore SEC and related filing metadata, where available.

ABANZA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ABANZA's valuation, stock price, and market status.

Is ABANZA a public or private company?

ABANZA is a private company.

What is the current stock price of ABANZA?

ABANZA is a private company with no public stock price. No recent secondary market data is available.

How much is ABANZA worth (valuation)?

Valuation information for ABANZA is not publicly available.

Can I buy ABANZA stock?

ABANZA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ABANZA's last funding round?

ABANZA's most recent funding round was Early Funding on September 4, 2024.

Who are the main investors in ABANZA?

Key investors in ABANZA include Sodena.

Will ABANZA IPO soon?

No public IPO plans have been announced for ABANZA.

How can I track ABANZA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ABANZA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNavarra
Employee Range16
Year Founded2014
Last FundingSep 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?